Receptor activator of nuclear factor-kappa B is enriched in CD9-positive extracellular vesicles released by osteoclasts

AIM: Receptor activator of nuclear factor-kappa B (RANK)-containing extracellular vesicles (EVs) bind RANK-Ligand (RANKL) on osteoblasts, and thereby simultaneously inhibit bone resorption and promote bone formation. Because of this, they are attractive candidates for therapeutic bone anabolic agent...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruan, Shaobo, Rody, Wellington J., Patel, Shivani S., Hammadi, Lina I., Martin, Macey L., de Faria, Lorraine P., Daaboul, George, Anderson, Leif S., He, Mei, Holliday, L. Shannon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629932/
https://www.ncbi.nlm.nih.gov/pubmed/37936884
http://dx.doi.org/10.20517/evcna.2023.38

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629932/
https://www.ncbi.nlm.nih.gov/pubmed/37936884
http://dx.doi.org/10.20517/evcna.2023.38

Ejemplares similares